Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Evoke delivers fifth straight quarter of YOY revenue growth

(Sharecast News) - Bookmaker Evoke said on Tuesday that it had delivered its fifth consecutive quarter of year-on-year revenue growth, with all three operating divisions delivering gains in the three months ended 30 September.

Evoke said group revenues rose 5% to £435m, or 4% on a constant currency basis, supported by a return to growth in its retail segment.

In the UK & Ireland, online revenue edged up 1%, with an 8% rise in sports offset by a 2% decline in gaming. Evoke also noted that its 888 brand's performance continued to weigh on growth, as marketing spend was reduced to prioritise higher returns. International revenue rose 8%, led by double-digit growth in Italy, Denmark and Romania, partially offset by softer trading in Spain and non-core markets.

Retail revenues climbed 6%, with balanced growth across sports and gaming, the latter supported by the rollout of new gaming cabinets.

Evoke also noted that it had completed a successful refinancing of its 2027 euro fixed-rate notes, issuing new 8.0% notes due 2031 amid strong investor demand. The move, alongside updated hedging arrangements, was expected to deliver around £5m in annualised cash interest savings, with no major maturities now due until 2028.

Chief executive Per Widerström said: "During Q3 we continued to execute against our strategy which is transforming our long-term competitive capabilities and building a more efficient and profitable business.

"We have clear plans in place to support an improvement in revenue during Q4 through continued acceleration in product enhancements, including retail sports and our recently launched new William Hill Vegas app. We are also making ongoing improvements to our customer lifecycle management capabilities. Alongside this, the improvements we have made to the operating model and efficiencies in our cost base mean we remain confident of achieving our implied Adjusted EBITDA guidance, which would outperform market expectations."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Culture Secretary 'minded to intervene' in Sky-ITV deal
(Sharecast News) - Culture secretary Lisa Nandy on Thursday revealed that she is "minded to intervene" in Sky's proposed takeover of ITV's media and entertainment activities, suggesting possible legislation of the streaming industry may be needed.
AstraZeneca enters into strategic drug discovery deal with AI biotech Insitro
(Sharecast News) - AstraZeneca said on Thursday that it will pay up to $1.86bn to enter a new strategic drug discovery collaboration and licensing agreement with Califiornia-based AI biotech firm Insitro.
Berenberg lifts target price on Discoverie following H1 update
(Sharecast News) - Analysts at Berenberg lifted their target price for DiscoverIE from 1,050p to 1,100p on Thursday, citing sustained organic momentum, a strengthening order book and earnings running ahead of expectations.
Friday preview: Man Group update, eurozone inflation eyed
(Sharecast News) - Friday will mark a fairly quiet end to a busy week that saw the release of a slew of US bank earnings.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.